COVID-19 Related Publications

Libby P, Lüscher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J. 2020. 41(32).3038–3044.

COVID BACKGROUNDER

Panigrahy  D, Gilligan MM, Huang S, et al. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19? Cancer Metastasis Rev. 2020.

Varga Z, Flammer AJ, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020. DOI:https://doi.org/10.1016/S0140-6736(20)30937-5. Epub ahead of print.

Das, UN. Can Bioactive Lipids Inactivate Coronavirus (COVID-19)? Arch Med Res. 2020. DOI: 10.1016/j.arcmed.2020.03.004. Epub ahead of print.

Mason RP, Libby P, Bhatt DL. Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid. Arterioscler Thromb Vasc Biol. 2020. DOI: 10.1161/ATVBAHA.119.313286. Epub ahead of print.

Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020. DOI:10.1001/jama.2020.6775.

Leger T,Azarnoush K, et al. Antioxidant and Cardioprotective Effects of EPA on Early Low-Severity Sepsis through UCP3 and SIRT3 Upholding of the Mitochondrial Redox Potential. Hindawi. 2019. https://doi.org/10.1155/2019/9710352.

Mason RP, Dawoud H, Jacob RF, Sherratt SCR, Malinski T. Eicosapentaenoic acid improves endothelial function and nitric oxide bioavailability in a manner that is enhanced in combination with a statin. Biomed Pharmacother. 2018;103:1231‐1237.

Chen H, Wang S, Zhao Y, Luo Y, Tong H, Su L. Correlation analysis of omega-3 fatty acids and mortality of sepsis and sepsis-induced ARDS in adults: data from previous randomized controlled trials. Nutr J. 2018;17:57.

Das UN. Combination of aspirin with essential fatty acids is superior to aspirin alone to prevent or ameliorate sepsis or ARDS. Lipids in Health and Disease. 2015;15:206.

Morita M, Kuba K, Ichikawa A, et al. The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell. 2013;153:112-25.

Baillie JK, Digard P. Influenza — Time to target the host? N Engl J Med. 2013; 369:191-193.

Supinski GS, Vanags J. & Callahan LA. Eicosapentaenoic acid preserves diaphragm force generation following endotoxin administration. Critical Care. 2010; 14:R35.

Calder PC. A novel effect of eicosapentaenoic acid: improved diaphragm strength in endotoxemia. Critical Care. 2010; 14:143.

Mickleborough TD, Tecklenburg SL, Montgomery GS, Lindley MR. Eicosapentaenoic acid is more effective than docosahexaenoic acid in inhibiting proinflammatory mediator production and transcription from LPS-induced human asthmatic alveolar macrophage cells. Clin Nutrition. 2009;28:71-77.